Concepedia

Author

Lee Anderson

University of California, Los AngelesORCID

Also Known As

L A Anderson, L ANDERSON, L Anderson, L. A. Anderson, L. Anderson, L.A. Anderson, Lauren A. Anderson, Lauren Ashley Anderson, Lee A. Anderson, Lee Anderson

55

Publications

4.7K

Citations

25

H-Index

50

Concepts

All Affiliations

University of California, Los AngelesUniversity of California, BerkeleyCedars-Sinai Medical CenterMayo ClinicJohns Hopkins University
LA

About

Lee Anderson is an author at University of California, Los Angeles specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

926

2

Cell Biology

8

8

470

3

Engineering

3

3

121

4

Health Sciences

1

1

14

5

Biology

1

1

69

Lee Anderson

×

31

Publications

4.6K

Citations

25

H-Index

YearCitations

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

Jeff Hall, Ming K. Lee, Beth Newman,

Science

1990

2.5K

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

Gottfried E. Konecny, Boris Winterhoff, Teodora Kolarova,

Clinical Cancer Research

2011

296

FOXA1 represses the molecular phenotype of basal breast cancer cells

Gina M. Bernardo, Gürkan Bebek, Charles Ginther,

Oncogene

2012

149

Periostin promotes ovarian cancer angiogenesis and metastasis

Min Zhu, Marlena S. Fejzo, Lee Anderson,

Gynecologic Oncology

2010

111

Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer

Maike Ihnen, Christine zu Eulenburg, Teodora Kolarova,

Molecular Cancer Therapeutics

2013

109

POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer

Beth Y. Karlan, Judy Dering, Christine Walsh,

Gynecologic Oncology

2013

108

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Joshua E. Logan, Nikayeh Mostofizadeh, Amrita Desai,

PubMed

2013

102

Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization

William D. Tap, Fritz C. Eilber, Charles Ginther,

Genes Chromosomes and Cancer

2010

93

THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.

A. Bowcock, Lee Anderson, Lori S. Friedman,

PubMed

1993

89

Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib

Ondrej Kalous, Dylan Conklin, Amrita Desai,

Molecular Cancer Therapeutics

2012

84

Page 1